Dallas, TX: ReportsandReports announce it will carry Covidien plc Market Share Analysis Market Research Report in its Store.
Browse complete Covidien plc Market Share Analysis Report
GlobalData’s medical devices report, “Covidien plc Market Share Analysis” provides in-depth information on Covidien’s market position in the different medical equipment markets it operates in. The report provides Covidien’s market share information in 13 key market categories – Respiratory Devices, Respiratory Disposables, Respiratory Measurement Devices, Electrosurgical Devices, Surgical Sutures, Advanced Wound Management, Compression Therapy, Traditional Wound Management, Wound Closure Devices, Patient Examination Devices, Syringes and Needles, Incontinence Devices, and Patient Monitoring Leads and Electrodes. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Global company shares (in Revenues) information for the key markets Covidien operates in – Anesthesia and Respiratory Devices, Surgical Equipment, Wound Care Management, Hospital Supplies, and Nephrology and Urology Devices. Other Key players covered include Ethicon, B Braun, ConvaTec, Coloplast, 3M Health Care, Cardinal Health, Becton, Dickinson, and Philips Healthcare, among others.
- Covidien’s company shares (in Revenues) information for all the key countries the company has presence in – United States, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- Covidien’s company shares (in Revenues) information for all the key market categories the company has presence in – Respiratory Devices, Respiratory Disposables, Respiratory Measurement Devices, Electrosurgical Devices, Surgical Sutures, Advanced Wound Management, Compression Therapy, Traditional Wound Management, Wound Closure Devices, Patient Examination Devices, Syringes and Needles, Incontinence Devices, and Patient Monitoring Leads and Electrodes.
- All the key data-points are for 2009 and cover all the key regions – North America, Europe, Asia Pacific (APAC), South Central America (SCA), and Middle East and Africa (MEA).
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any – Mergers & Acquisitions (M&A), Asset Transactions, PE/VC, Equity Offerings, Debt Offerings, and Partnerships.
Reasons to buy
- Develop sales and marketing strategies by identifying who-stands-where in the markets, Covidien operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Covidien’s market positions.
1 Table of Contents
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 16
2.1 What Is This Report About? 16
3 Definitions of Markets/Categories Covered 17
3.1 Anesthesia and Respiratory Devices 17
3.1.1 Respiratory Devices 17
3.1.2 Respiratory Disposables 17
3.1.3 Respiratory Measurement Devices 17
3.2 Surgical Equipment 17
3.2.1 Electrosurgical Devices 17
3.2.2 Surgical Sutures 17
3.3 Wound Care Management 18
3.3.1 Advanced Wound Management 18
3.3.2 Compression Therapy 18
3.3.3 Traditional Wound Management 18
3.3.4 Wound Closure Devices 18
3.4 Hospital Supplies 18
3.4.1 Patient Examination Devices 18
3.4.2 Syringes and Needles 18
3.5 Nephrology and Urology Devices 19
3.5.1 Incontinence Devices 19
3.6 Patient Monitoring 19
3.6.1 Patient Monitoring Leads and Electrodes 19
4 Company Snapshot 20
4.1 Key Information 20
4.2 Company Overview 20
4.3 Financial Performance 20
4.4 SWOT Snapshot 20
5 Business Description 21
5.1 Business Overview 21
5.2 Medical Devices 21
5.2.1 Overview 21
5.2.2 Financials 21
5.2.3 Capital Expenditure 21
5.2.4 Market View 22
5.2.5 Key Strategies 22
5.3 Medical Supplies 22
5.3.1 Overview 22
5.3.2 Financials 22
5.3.3 Capital Expenditure 22
5.3.4 Market View 22
5.3.5 Key Strategies 22
5.4 Pharmaceuticals Products 22
5.4.1 Overview 22
5.4.2 Financials 22
5.4.3 Capital Expenditure 23
5.4.4 Market View 23
5.4.5 Key Strategies 23
5.5 Major Products and Services 24
5.5.1 Overview 24
6 History 25
7 Business Strategy 28
7.1 Mission Statement 28
8 SWOT Analysis 29
8.1 Overview 29
8.2 Covidien plc Strengths 29
8.2.1 Intense Focus on Innovation 29
8.2.2 Diversified Global Presence 30
8.2.3 Brand Equity 30
8.2.4 Extensive Product Base 30
8.3 Covidien plc Weaknesses 31
8.3.1 Declining Market Share in the Sector 31
8.3.2 Decline in Profitability Ratios 31
8.3.3 Weak Bottom Line 31
8.3.4 Voluntary Product Recalls 31
8.4 Covidien plc Opportunities 31
8.4.1 New Product Launches 31
8.4.2 Recognition 32
8.4.3 Market Growth in Emerging Economies 32
8.4.4 Inorganic Growth Strategy 32
8.5 Covidien plc Threats 32
8.5.1 Industry Consolidation Challenges 32
8.5.2 Rapid Technological Change 33
8.5.3 Rising Oil Prices 33
8.5.4 Product Liability Claims 33
8.5.5 Cost Containment Pressures 33
9 Competitors 34
10 Competitive Landscape 36
10.1 Anesthesia and Respiratory Devices, Global, Company Share (%), 2009 36
10.2 Surgical Equipment, Global, Company Share (%), 2009 38
10.3 Wound Care Management, Global, Company Share (%), 2009 39
10.4 Hospital Supplies, Global, Company Share (%), 2009 41
10.5 Nephrology and Urology Devices, Global, Company Share (%), 2009 43
10.6 Patient Monitoring, Global, Company Share (%), 2009 45
11 Covidien plc Medical Equipment Market Share Analysis 47
11.1 Covidien plc, Global, Market Share (2009) 47
11.2 Covidien plc, Asia-Pacific, Market Share (2009) 49
11.2.1 Covidien plc, Australia, Market Share (2009) 51
11.2.2 Covidien plc, China, Market Share (2009) 53
11.2.3 Covidien plc, India, Market Share (2009) 55
11.2.4 Covidien plc, Japan, Market Share (2009) 57
11.2.5 Covidien plc, Other Asia-Pacific, Market Share (2009) 59
11.3 Covidien plc, Europe, Market Share (2009) 61
11.3.1 Covidien plc, France, Market Share (2009) 63
11.3.2 Covidien plc, Germany, Market Share (2009) 65
11.3.3 Covidien plc, Italy, Market Share (2009) 67
11.3.4 Covidien plc, Spain, Market Share (2009) 69
11.3.5 Covidien plc, United Kingdom, Market Share (2009) 71
11.3.6 Covidien plc, Other Europe, Market Share (2009) 73
11.4 Covidien plc, Middle East and Africa, Market Share (2009) 75
11.5 Covidien plc, North America, Market Share (2009) 77
11.5.1 Covidien plc, Canada, Market Share (2009) 79
11.5.2 Covidien plc, United States, Market Share (2009) 81
11.6 Covidien plc, South and Central America, Market Share (2009) 83
11.6.1 Covidien plc, Brazil, Market Share (2009) 85
11.6.2 Covidien plc, Other South and Central America, Market Share (2009) 87
12 Covidien plc Medical Equipment Market Share Analysis by Category 89
12.1 Covidien plc, Global, Category Revenue Share (2009) 89
12.2 Covidien plc, Asia-Pacific, Category Revenue Share (2009) 92
12.2.1 Covidien plc, Australia, Category Revenue Share (2009) 95
12.2.2 Covidien plc, China, Category Revenue Share (2009) 98
12.2.3 Covidien plc, India, Category Revenue Share (2009) 101
12.2.4 Covidien plc, Japan, Category Revenue Share (2009) 104
12.2.5 Covidien plc, Other Asia-Pacific, Category Revenue Share (2009) 107
12.3 Covidien plc, Europe, Category Revenue Share (2009) 110
12.3.1 Covidien plc, France, Category Revenue Share (2009) 113
12.3.2 Covidien plc, Germany, Category Revenue Share (2009) 116
12.3.3 Covidien plc, Italy, Category Revenue Share (2009) 119
12.3.4 Covidien plc, Spain, Category Revenue Share (2009) 122
12.3.5 Covidien plc, United Kingdom, Category Revenue Share (2009) 125
12.3.6 Covidien plc, Other Europe, Category Revenue Share (2009) 128
12.4 Covidien plc, Middle East and Africa, Category Revenue Share (2009) 131
12.5 Covidien plc, North America, Category Revenue Share (2009) 134
12.5.1 Covidien plc, Canada, Category Revenue Share (2009) 137
12.5.2 Covidien plc, United States, Category Revenue Share (2009) 140
12.6 Covidien plc, South and Central America, Category Revenue Share (2009) 143
12.6.1 Covidien plc, Brazil, Category Revenue Share (2009) 146
12.6.2 Covidien plc, Other South and Central America, Category Revenue Share (2009) 149
13 Share Holding Structure 152
14 Key Employees 153
15 Key Employee Biographies 154
16 Company Statement 156
17 Locations And Subsidiaries 159
17.1 Head Office 159
17.2 Other Locations & Subsidiaries 159
18 Financial Deals Landscape 161
18.1 Covidien plc, Deals Volume Summary, 2005 to YTD 2010 161
19 Covidien plc, Deals Summary By Region, 2005 to YTD 2010 162
20 Covidien plc Detailed Deal Summary 165
20.1 Asset Purchase 165
20.1.1 Orthofix International Completes Sale Of Vascular Business To Covidien 165
20.1.2 Covidien Acquires Injection Devices From Pinyons Medical Technology 167
20.1.3 U.S. Surgical Acquires Absorbatack From Sorbx 168
20.2 Venture Financing 169
20.2.1 Power Medical Interventions Secures $14.5 Million In Series C Round Of Financing 169
20.2.2 Power Medical Interventions Secures $35 Million In Series B Round Of Financing 170
20.3 Partnerships 171
20.3.1 Power Medical Interventions Enters Into An Agreement With Intuitive Surgical 171
20.3.2 AngioDynamics Signs An Agreement With VNUS Medical Technologies 172
20.3.3 Covidien Signs An Agreement With NewSouth Innovations 173
20.3.4 Criticare Systems And Nellcor Puritan Bennett Enter Into A Licensing Agreement 174
20.3.5 Covidien Enters Into An Agreement With Philips Healthcare 175
20.3.6 Covidien Enters Into An Agreement With Drager Medical 176
20.4 Equity Offering 177
20.4.1 Power Medical Interventions Completes Initial Public Offering Of $42.35 Million 177
20.4.2 VNUS Medical Technologies Completes Initial Public Offering Of $60 Million 178
20.5 Divestiture – Assets 179
20.5.1 Covidien Completes Sale Of Oxygen Therapy Products To Chart Industries 179
20.5.2 Covidien Sells Sleep Diagnostics Products To Embla Systems 180
20.5.3 Covidien Plans To Sell Sleep Therapy Product 181
20.6 Acquisition 182
20.6.1 Covidien Completes Acquisition Of Aspect Medical Systems 182
20.6.2 Covidien Completes Acquisition Of Power Medical Interventions 184
20.6.3 Covidien Acquires VNUS Medical Technologies 185
20.6.4 Covidien Completes Acquisition Of Bacchus Vascular 187
21 Recent Developments 188
21.1 Strategy And Business Planning 188
21.1.1 Jun 17, 2009: Neuromed Sells US Rights Of Exalgo To Covidien 188
21.1.2 Apr 26, 2009: Covidien Enters Into Indian Market, Establishes Headquarters At Gurgaon, India 188
21.1.3 Mar 08, 2009: Covidien Will Close New York Production Plant 188
21.1.4 Oct 13, 2008: Covidien Opens Extension In Dublin, Ireland 189
21.1.5 Aug 24, 2008: Covidien Seeks Expansion And Tax Relief To Expand In Mansfield 189
21.1.6 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent 189
21.2 Financial Announcements 189
21.2.1 Apr 21, 2010: Covidien Reports Net Income Of $413 Million In Q2 Fiscal 2010 189
21.2.2 Jan 20, 2010: Covidien Reports Net Income Of $412 Million In Q1 Fiscal 2010 191
21.2.3 Nov 17, 2009: Covidien Reports Net Sales Of $10.67 Billion In Fiscal 2009 193
21.2.4 Jul 30, 2009: Covidien Posts $281 Million Net Income In Q3 Fiscal 2009 195
21.3 Research And Development 196
21.3.1 Feb 16, 2010: Covidien: Study Finds TaperGuard Line of Endotracheal Tubes Reduces Microaspiration 196
21.3.2 Sep 02, 2008: Covidien To Buy Building In Mansfield For R&D And Administrative Space 197
21.3.3 Jun 19, 2008: Covidien Announces Latest Advance In ”Unite To Treat Sleep Apnea” Initiative 197
21.3.4 Oct 15, 2007: Covidien, BioSynthema Signs Agreements To Develop And Commercialize Nuclear Medicine Therapy 198
21.4 Corporate Communications 198
21.4.1 Sep 21, 2009: Covidien To Lay Off Around 70 Workforce At Its Norfolk Medical Supplies Plant 198
21.4.2 Jul 08, 2009: Covidien Lays Off 119 Workers From Its Seneca Plant 199
21.4.3 Sep 29, 2008: Covidien Elects New Chairman 199
21.4.4 Jun 30, 2008: Covidien Appoints New R&D Executives In Its Pharmaceutical And Imaging Businesses 199
21.4.5 Jun 30, 2008: Covidien Announces Management Appointments 201
21.5 Legal and Regulatory 202
21.5.1 May 12, 2010: Covidien Resolves Patent Case With Kimberly-Clark 202
21.5.2 Mar 22, 2010: Covidien Prevails In Patent Litigation Against Applied Medical 202
21.5.3 Jan 14, 2010: Covidien Sues Ethicon Endo- Surgery Over Ultrasonic Surgical Devices 202
21.5.4 Jan 11, 2010: Masimo Receives Payment Following Court Of Appeals Affirmance Of Antitrust Liability Verdict Against Tyco HealthCare 203
21.5.5 Nov 02, 2009: Masimo Says Appeals Court Upholds Antitrust Liability Verdict Against Tyco 203
21.5.6 May 04, 2009: Attorney General Cox, Treasurer Kleine Recover $24.5 Million For State Pension Fund 204
21.5.7 Apr 21, 2009: Covidien Files Patent Infringement Lawsuit Against Davol 204
21.5.8 Jan 15, 2009: Rochester Announces Settlement With Covidien To Resolve Litigation 205
21.6 Government and Public Interest 205
21.6.1 Dec 04, 2009: eMDR Rule Could Hurt Device Companies 205
21.6.2 Aug 04, 2009: FDA Extends Review Of Pennsaid Diclofenac Sodium Topical Solution 205
21.7 Product News 206
21.7.1 Jun 23, 2010: Covidien Launches Endo GIA Reloads With Tri-Staple technology And Endo GIA Ultra Universal Stapler At ASMBS Annual Meeting 206
21.7.2 May 27, 2010: Covidien Launches V-Loc 90 Wound Closure Device For Knotless Tissue Repair 206
21.7.3 May 20, 2010: Covidien Initiates Voluntary Recall Of Certain Shiley Tracheostomy Tubes 207
21.7.4 May 18, 2010: Covidien Launches SILS Stitch Suturing Device For Advanced Laparoscopic Surgery 207
21.7.5 May 17, 2010: Covidien Launches EEA Hemorrhoid & Prolapse Stapler Set 207
21.7.6 May 06, 2010: Covidien Receives FDA 510(k) Clearance For Puritan Bennett 840 Ventilator To Extend Minimum Delivered Tidal Volume For Neonatal Patients 208
21.7.7 Apr 19, 2010: Covidien Initiates Innovation: Delivered Tour For SILS Port Multiple Instrument Access Device 209
21.7.8 Feb 16, 2010: Covidien Plans To Complete SILS Port Laparoscopic Cholecystectomy Post Market Study In Third Quarter Of 2011 209
21.7.9 Feb 15, 2010: Covidien To Complete Clinical Trial For Duet TRS In First Half Of 2010 210
21.7.10 Feb 15, 2010: Covidien To Complete Phase IV Trial For V-Loc 180 Absorbable Wound Closure Device In Second Quarter Of 2011 210
21.7.11 Jan 09, 2010: Covidien Plans To Complete Phase I Netherlands Trial For Parietene Composite Mesh In Second Half Of 2012 210
21.7.12 Nov 11, 2009: Covidien Unveils DuraSeal Spine Sealant 211
21.7.13 Oct 19, 2009: Covidien Launches Mallinckrodt TaperGuard And TaperGuard Evac Endotracheal Tubes 211
21.7.14 Oct 12, 2009: Covidien Announces Worldwide Launch Of V-Loc Absorbable Wound Closure Device 212
21.7.15 Sep 30, 2009: Covidien Announces FDA Approval For Mallinckrodt TaperGuard Evac Endotracheal Tube 212
21.7.16 Sep 11, 2009: Covidien Announces Class I Recall For Pedi-Cap End-Tidal CO2 Detectors 213
21.7.17 Sep 09, 2009: Covidien Launches AbsorbaTack 20 Short Fixation Device And Parietex Lightweight Monofilament Polyester Mesh At International Hernia Congress 213
21.7.18 Aug 24, 2009: Covidien Launches Its New Automatic Leak Adjustments Software Option For The Puritan Bennett 840 Ventilator 214
21.7.19 Aug 17, 2009: Covidien Introduces NeoMode Software Upgrade For Puritan Bennett 840 Ventilator 215
21.7.20 Aug 13, 2009: Iowa Health System Adopts Covidien Nellcor OxiMax Pulse Oximetry Products 215
21.8 Other Significant Developments 216
21.8.1 Mar 03, 2010: Covidien Announces Preferred Vendor Partnership With OSF Healthcare System For Nellcor OxiMax Pulse Oximetry Products 216
21.8.2 Feb 05, 2010: Premier Awards New Contracts For Bedside Procedure Trays And Needles To Busse Hospital Disposables, CareFusion 2200 And Covidien 216
21.8.3 Sep 03, 2009: Covidien Reveals Reporting Changes 217
21.8.4 Aug 13, 2009: Covidien’s Nellcor OxiMax Pulse Oximetry Products Adopted By IHS 217
22 Appendix 218
22.1 Research Methodology 219
22.2 Secondary Research 220
22.3 Primary Research 220
22.4 Models 221
22.5 Forecasts 221
22.6 Expert Panels 221
22.7 GlobalData Consulting 221
22.8 Currency Conversion 222
22.9 Contact Us 223
22.10 Disclaimer 223
Browse complete Covidien plc Market Share Analysis Report
Browse all Medical Devices Market Research Reports
Browse all GlobalData Market Research Reports
Browse all Latest Report
Related Reports:
Covidien plc-Deals & Alliances Report
Dameca a/s Market Share Analysis
Medison Co., Ltd. Market Share Analysis
About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/
